Houston, TX Author Publishes NCLEX Review Book
By:
PR Leap
June 12, 2025 at 03:00 AM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
(PRLeap.com) "NCLEX Strategy and Pharmacology Review Book", a new book by Julie Chinwe Anyanwu, RN, NPCH, MSN, has been released by Dorrance Publishing Co., Inc.The purpose of this book is to offer strategies for answering questions concerning content, prioritization, pharmacology, and Next Generation exam questions to nurse students preparing for the NCLEX Exam and those taking the test again.
"NCLEX Strategy and Pharmacology Review Book" is a 198-page paperback with a retail price of $63.00 (eBook $58.00). The ISBN is 979-8-89211-149-2. Published by Dorrance Publishing Co., Inc. of Pittsburgh, Pennsylvania. For members of the press, to request a review copy or author interview, please visit https://bookstore.dorrancepublishing.com/pages/media-requests or to buy the book, visit our online bookstore at https://bookstore.dorrancepublishing.com/products/nclex-strategy-and-pharmacology-review-book
GET IN TOUCH
Natasha Hlinka
Dorrance Publishing
http://www.dorrancepublishing.com
You can see the original version and more on PRLeap here: http://www.prleap.com/pr/305530/houston-tx-author-publishes-nclex-review-book
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View More
Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets ↗
Today 13:25 EDT
Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case ↗
Today 12:50 EDT
Hershey Stock May Be Near a Sweet Spot as Cocoa Pressure Eases ↗
Today 12:15 EDT
Via MarketBeat
Tickers
HSY
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>